| Approved? (Admin-only) |
|
|---|---|
| Opportunity Type | Funding Opportunity Announcement (FOA) |
| Funding Opportunity Posted By | DOD |
| Component | DHA - CDMRP |
| Funding Opportunity Title | Tuberous Sclerosis Complex Research Program (TSCRP) |
| Opportunity ID | HT942526TSCRPEHDA, |
| Link to Funding Opportunity | ebrap.org |
| Funding Opportunity Short Description | CDMRP Tuberous Sclerosis Complex Research Program(TSCRP) |
| Funding Opportunity Category | Health and Biomedical Technologies |
| Important Dates | |
| Open Date | 05/06/2026 |
| White Paper / Pre-Proposal / Solution Summary Due | 07/23/2026 |
| Full Applications Due | 08/06/2026 |
| Funding Details | |
| Funding Mechanism |
|
| Eligibility |
|
| Assistance Listings | 12.420 -- Military Medical Research and Development |
| Required Registrations |
|
| Funding Opportunity Full Description | The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CTRA) supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis or treatment of tuberous sclerosis complex (TSC). The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Idea Development Award (IDA) supports conceptually innovative and high-impact research that could ultimately lead to critical discoveries in tuberous sclerosis complex (TSC) research and/or improvements in patient care. The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain and potentially groundbreaking concepts in the tuberous sclerosis complex (TSC) research field. |
